Pfizer approaches Medivation about potential takeover: sources
New York
PFIZER Inc has approached US cancer drug maker Medivation Inc to express interest in an acquisition, raising the possibility of a bid rivalling a US$9.3 billion offer by Sanofi SA, people familiar with the matter said on Tuesday.
Pfizer's approach comes less than a week after Sanofi went public with its US$52.50 per share cash offer, complaining that Medivation refused to engage. Medivation subsequently rejected the offer as too low. Its shares closed on Tuesday at US$57.52.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action